Table 4.
Distribution of antibiotics prescribed based on indications
| Antibiotic | CI | HI | SP3 | MP | UI |
|---|---|---|---|---|---|
| Ciprofloxacin | 29 (16.7) | 8 (11.0) | 7 (6.9) | 4 (6.0) | 7 (20.6) |
| Levofloxacin | 4 (2.3) | 0 (0.0) | 1 (1.0) | 1 (1.5) | 0 (0.0) |
| Ceftriaxone | 21 (12.1) | 6 (8.2) | 8 (7.9) | 13 (19.4) | 6 (17.6) |
| Cefuroxime | 6 (3.4) | 2 (2.7) | 9 (8.9) | 0 (0.0) | 0 (0.0) |
| Cefixime | 4 (2.3) | 4 (5.5) | 13 (12.9) | 0 (0.0) | 1 (2.9) |
| Ceftazidime | 1 (0.6) | 5 (6.8) | 0 (0.0) | 3 (4.5) | 0 (0.0) |
| Metronidazole | 41 (23.6) | 15 (20.5) | 21 (20.8) | 11 (16.4) | 11 (32.4) |
| Tinidazole | 5 (2.9) | 7 (9.6) | 13 (12.9) | 2 (3.0) | 1 (2.9) |
| Secnidazole | 0 (0.0) | 1 (1.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Ampicillin-sulbactam | 2 (1.1) | 3 (4.1) | 0 (0.0) | 1 (1.5) | 1 (2.9) |
| Amoxicillin-clavulanate | 16 (9.2) | 5 (6.8) | 11 (10.9) | 6 (9.0) | 2 (5.9) |
| Amoxicillin | 6 (3.4) | 2 (2.7) | 8 (7.9) | 1 (1.5) | 1 (2.9) |
| Ampicillin-cloxacillin | 1 (0.6) | 1 (1.4) | 0 (0.0) | 8 (11.9) | 1 (2.9) |
| Ampicillin-floxacillin | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (2.9) |
| Crystalline penicillin | 4 (2.3) | 1 (1.4) | 0 (0.0) | 3 (4.5) | 0 (0.0) |
| Erythromycin | 1 (0.6) | 0 (0.0) | 1 (1.0) | 0 (0.0) | 0 (0.0) |
| Azithromycin | 5 (2.9) | 0 (0.0) | 0 (0.0) | 1 (1.5) | 0 (0.0) |
| Cotrimoxazole | 2 (1.1) | 1 (1.4) | 0 (0.0) | 1 (1.5) | 0 (0.0) |
| Doxycycline | 1 (0.6) | 0 (0.0) | 2 (2.0) | 0 (0.0) | 1 (2.9) |
| Chloramphenicol | 3 (1.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Gentamicin | 13 (7.5) | 10 (13.7) | 4 (4.0) | 10 (14.9) | 1 (2.9) |
| Clindamycin | 9 (5.2) | 1 (1.4) | 3 (3.0) | 1 (1.5) | 0 (0.0) |
| Meropenem | 0 (0.0) | 1 (1.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Nitrofurantoin | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.5) | 0 (0.0) |
CI Community acquired infections, HI Hospital acquired infections, SP Surgical prophylaxis, MP Medical prophylaxis and UI Unknown indication